Identity and synonyms
Published sequence descriptions are not consistent across retrieved records; withhold sequence pending reconciliation.
Peptide or peptide-related · Peptide or peptide derivative
Detailed molecular class: Bioregulator peptide
Supplied sequence or chemical reference
See identity note; no supplier sequence accepted as verification.
Mechanism
Investigated in bronchial epithelial remodeling and inflammatory pathways.
Evidence and critical reading
Reported scientific and empirical uses
Respiratory function
Bioregulator promoted for bronchial epithelium/lung function.
Human evidence
No controlled human efficacy finding was verified for the exact catalog identity in this screen.
Preclinical evidence
Rat obstructive-lung models reported histological and inflammatory changes.
Critical reading and limitations
Selected studies are obstructive rat models, not a proven human COPD therapy.
Evidence applies to the exact molecule, formulation, route, population and endpoint studied. Supplier identity, purity and clinical equivalence are unverified.
Source-specific regimens
Descriptive source observations, not individual recommendations.
Regulatory product labeling
No numerical human dose is assigned: reviewed sources did not verify a regimen attributable to this material, route and indication. Other molecules’ doses, animal exposures, vial amounts and dietary requirements are not substituted.
Human-study exposure
No numerical human dose is assigned: reviewed sources did not verify a regimen attributable to this material, route and indication. Other molecules’ doses, animal exposures, vial amounts and dietary requirements are not substituted.
Empirical handbook
No numerical human dose is assigned: reviewed sources did not verify a regimen attributable to this material, route and indication. Other molecules’ doses, animal exposures, vial amounts and dietary requirements are not substituted.
Regulation and safety
Jurisdiction-specific regulatory context
Jurisdiction-specific approval not verified in this card; do not infer global nonapproval.
Adverse effects and unknowns
Human safety, contraindications and interactions are not adequately established for the catalog product. Missing reports are not evidence of safety.
Sequence descriptions conflict across records: withhold structure until reconciled.
Contraindications
See supported safety statements and exact product label; a complete contraindication set has not been established for this catalog material.
A complete list must match the exact authorized product. For experimental materials without verified human labeling, a complete contraindication set is not established here. No list does not mean safety.
Interactions
Only explicitly cited interactions may be asserted; unstudied combinations remain unknown, not interaction-free.
Separate documented interaction, pharmacologic plausibility and unknown interaction. Absence of a blend trial does not establish compatibility.
Studies and trials
Selected studies
PMID22117547 · Cell experiment
HeLa cells/DNA assays.
Fluorescent peptides, in vitro.
Nuclear penetration/DNA interaction.
Labeling/culture are not patient-vial distribution or benefit.
Trials attributed in the package
No trials are attributed in this record.
Trial registration does not establish efficacy or validate commercial material.
Query candidates; attribution pending
Bronchogen · 1 unfiltered query results, not authenticated trials
Query verification: October 16, 2026
Exact phrase intervention query; first three most recently updated records, not exhaustive. Aliases may be missed and heterogeneous products may appear. The total is the unfiltered registry query count, not authenticated trials. Source-integrity holds are excluded from ordinary listings.
View trial registry queryNCT00746759 · Airway Epithelium Gene Expression: AEGIS IDERegistry status: CompletedLast update posted: June 4, 2015Query verification: October 16, 2026
Source issues and references
References include queries and bibliographic handbook attributions; not all are clinical studies. Human review remains pending.
- PMID22117547
Fedoreyeva LI, Kireev II, Khavinson VKh, Vanyushin BF.
October 16, 2026
- PMID26468022
Kuzubova NA, Lebedeva ES, Dvorakovskaya IV, Surkova EA, Platonova IS, Titova ON.
October 16, 2026
- PMID30199201
Titova ON, Kuzubova NA, Lebedeva ES, Preobrazhenskaya TN, Surkova EA, Dvorakovskaya IV.
October 16, 2026
- pdf01
PEPNEXA 2.pdf
October 16, 2026
- pdf05
PEPNEXA.pdf
October 16, 2026
- pdf07
US Peptide MangerCorp(1).pdf
October 16, 2026
- pdf09
PeptideFactory.pdf
October 16, 2026